the role of medical affairs in shaping brand development princeton pharma compliance conference june...
TRANSCRIPT
![Page 1: The Role of Medical Affairs in Shaping Brand Development PRINCETON PHARMA COMPLIANCE CONFERENCE June 7, 2004 Michael Edwin Kafrissen, MD, MSPH](https://reader036.vdocuments.us/reader036/viewer/2022082713/56649e665503460f94b6167d/html5/thumbnails/1.jpg)
The Role of Medical Affairs in Shaping Brand Development
PRINCETON PHARMA COMPLIANCE CONFERENCE
June 7, 2004
Michael Edwin Kafrissen, MD, MSPH
![Page 2: The Role of Medical Affairs in Shaping Brand Development PRINCETON PHARMA COMPLIANCE CONFERENCE June 7, 2004 Michael Edwin Kafrissen, MD, MSPH](https://reader036.vdocuments.us/reader036/viewer/2022082713/56649e665503460f94b6167d/html5/thumbnails/2.jpg)
Key Themes
• Changing Environment – Changing Roles for Medical Affairs
• Medical Affairs and Its Partners – How the Elements of the Company Differ
• Clinical Commercial Optimization – Planning vs. Reaction
• Enablers and Obstacles
![Page 3: The Role of Medical Affairs in Shaping Brand Development PRINCETON PHARMA COMPLIANCE CONFERENCE June 7, 2004 Michael Edwin Kafrissen, MD, MSPH](https://reader036.vdocuments.us/reader036/viewer/2022082713/56649e665503460f94b6167d/html5/thumbnails/3.jpg)
Medical Affairs and HCC
• Clinical commercial optimization requires specialized skills, involvement beginning in development and extending through life cycle.
• A mastery of HCC facilitates not only legal and ethical behavior but also commercial success.
![Page 4: The Role of Medical Affairs in Shaping Brand Development PRINCETON PHARMA COMPLIANCE CONFERENCE June 7, 2004 Michael Edwin Kafrissen, MD, MSPH](https://reader036.vdocuments.us/reader036/viewer/2022082713/56649e665503460f94b6167d/html5/thumbnails/4.jpg)
Changing Environment – Changing Roles
1. What we demonstrate is what we can say – label, publication, evidence-base.
2. HCC codifies business ethics and good science – neither meets universal agreement.
3. Pipeline, development costs, margins – the product/molecule life cycle value.
4. Customer types, customer expectations.
![Page 5: The Role of Medical Affairs in Shaping Brand Development PRINCETON PHARMA COMPLIANCE CONFERENCE June 7, 2004 Michael Edwin Kafrissen, MD, MSPH](https://reader036.vdocuments.us/reader036/viewer/2022082713/56649e665503460f94b6167d/html5/thumbnails/5.jpg)
Medical Affairs and Partners – Time & Space*
DivisionDivision TimeTime FocusFocus
Research Development
3-10 Years + Drug to Development Approval
Medical Affairs Crisis-7 Years Life Cycle
New Product 2-3 Years Launch
Brand ¼ - 1 Year Market & Share
Sales Week – 1 Year Comp. Plan
* Rough examples for discussion.
![Page 6: The Role of Medical Affairs in Shaping Brand Development PRINCETON PHARMA COMPLIANCE CONFERENCE June 7, 2004 Michael Edwin Kafrissen, MD, MSPH](https://reader036.vdocuments.us/reader036/viewer/2022082713/56649e665503460f94b6167d/html5/thumbnails/6.jpg)
Clinical Commercial Optimization Planning Steps
• Understand molecule, clinical issues, customer drivers.• Early advice from experts, KOL’s, promotional partners.• Develop clinical, epidemiologic, outcomes, and publication
plan.• Influence requires expertise – team may evolve.• Execution requires expertise – team may evolve.• Information must be in place to permit appropriate
adoption, including CME.• Flexibility – new data, new technology, competitive
activity.
![Page 7: The Role of Medical Affairs in Shaping Brand Development PRINCETON PHARMA COMPLIANCE CONFERENCE June 7, 2004 Michael Edwin Kafrissen, MD, MSPH](https://reader036.vdocuments.us/reader036/viewer/2022082713/56649e665503460f94b6167d/html5/thumbnails/7.jpg)
• As customers consolidate, evidence is demanded, and regulation clarifies, Medical Affairs role will grow in life cycle planning, execution, communication, and episodic issue management.
• Each product/molecule must be characterized appropriately and developed to its optimal extent. A skilled and enabled Medical Affairs function is the best investment for the foreseeable future.